Nexium Capsules RE Maintenance Specific Clinical Experience Investigation

Nexium Capsules Specific Clinical Experience Investigation for Maintenance Therapy for Repeatedly Recurring/Relapsing Reflux Oesophagitis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01562639

Enrollment

647

Registered

2012-03-26

Start date

2012-04-30

Completion date

2014-07-31

Last updated

2014-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Relapsing Reflux Esophagitis, Repeatedly Recurring Esophagitis

Keywords

maintenance therapy,, repeatedly recurring,, relapsing reflux oesophagitis,, Nexium

Brief summary

The purpose of this study is to collect following data in patients given Nexium capsule (Nexium) in usual post-marketing use as the maintenance therapy for repeatedly recurring/relapsing reflux oesophagitis.

Detailed description

Nexium capsules Specific Clinical Experience Investigation for Maintenance Therapy for Repeatedly Recurring/Relapsing Reflux Oesophagitis

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients with repeatedly recurring/relapsing reflux oesophagitis who will be given Nexium for the first time as a maintenance therapy.

Exclusion criteria

* Patients having reflux oesophagitis when Nexium is started (Grade A, Grade B, Grade C or Grade D of Los Angeles Classification (Hoshihara's modification) on endoscopy) * Patients having previous history of maintenance therapy for repeatedly recurring/ relapsing reflux oesophagitis

Design outcomes

Primary

Measure	Time frame	Description
Number of Adverse Drug Reactions	6 Month	Adverse event incidence

Secondary

Measure	Time frame
Non-recurrence rate of reflux oesophagitis	6 Month

Countries

Japan

Outcome results